|
|
|
|
Science Sparks @ ACTREC
|
26th October 2026 |
Vol. No. 15 ; Issue No.759 |
|
|
Publications
|
|
1. Darekar K, Patil BJ, Bhavke AA, Gayake UB, Raveendran V, Punde RN, Shinde PH, Dhole SD, Arunasalam CP, Chaudhari L, Laskar S, Phurailatpam RD (2026). Fabrication, testing, and clinical validation of an epoxy resin-based range shifter for pencil beam scanning proton therapy. Biomedical Physics and Engineering Express.
2. Desai P, Navkudkar A, Suresh A, Sengar M, Jain H, Bagal B, Nayak L, Shetty A, Purwar R, Karulkar A, Kalra D, Ravikumar S, Tembhare P (2027). Process Characterization and Determinants of CD3⁺ Cell Yield During Autologous Leukapheresis for CAR-T Cell Manufacturing: A Single-Centre Experience from Western India. Hematology, Transfusion and Cell Therapy. 49(1):108545.
3. Raj JAT, Chatterjee A, Gadewal N, Goda JS (2026). Computational identification of phytochemical NMDAR pore-targeting candidates for radiation-induced cognitive decline. In Silico Pharmacology.14(3):258.
4. Patel P, Hole A, Banerjee S, Gupta S, CM Krishna (2026). Biochemical Remodeling During Progressive Doxorubicin Resistance in Cervical Cancer Cells Revealed by Raman Spectroscopy. Vibrational Spectroscopy.
5. Patkar S, Kale KD, Kazi M, Dhaiya A, Goel M (2026). Impact of the Prognostic Nutritional Index on Outcomes in Resectable Gallbladder Cancer. Annals of Surgical Oncology.
6. Anchan SS, Kohinkar PS, Bhandari YG, Gawde J, Adhvaryu VV, Rane S, Thorat R, Mahimkar MB (2026). A modified 4NQO-induced oral carcinogenesis model defines a chemopreventive intervention window and reveals progression-modulatory effects of black tea polyphenols. Carcinogenesis.
7. Bagwan AI, Parray AM, Kumar A, Chopde A, Patkar S, Bhandare M, Bhargav P, Yadav S, Patil S, Ostwal V, Ramaswamy A, Ramadwar M, Shrikhande SV, Mahesh G, Chaudhari VA (2026). Long-term Outcomes of Surgery for Metastatic and Recurrent Gastrointestinal Stromal Tumours in the Tyrosine Kinase Inhibitor Era: A 14-Year Single-Centre Experience from a Tertiary Cancer Centre in India. Journal of Gastrointestinal Surgery.
|
|
|
|
|
Interesting Reads
|
|
Magrangeas F, Cherkaoui M, Bessonneau-Gaborit V, Derrien J, Chevalier C, Guérin-Charbonnel C, Diamond B, Samur MK; Intergroupe Francophone du Myélome (IFM); Hulin C, Caillot D, Karlin L, Arnulf B, Landgren O, Munshi NC, Avet-Loiseau H, Martinet L, Corre J, Perrot A, Moreau P, Touzeau C, Minvielle S, Letouzé E (2026). Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy. Nature Medicine.
|
|
|
Video of the Week
|
|
| The Gut Microbiome and Cancer: From research discoveries to veterinary clinical trials
|
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 1997, FDA approved Rituxan (rituximab), the first monoclonal antibody, to treat non-Hodgkin’s lymphoma.
|
|
|
|
Cancer News
|
| |
|
Scientists discover a hidden immune weapon against deadly lung cancer.
|
|
ScienceDaily, 22/10/2026
|
|
Researchers have uncovered a hidden immune defense capable of attacking small cell lung cancer, an extremely aggressive disease that often escapes conventional treatments. The specialized immune cells can recognize and destroy cancer cells even when tumors...
|
| |
|
Dr CS Pramesh Elected UICC President-elect for 2026–2028.
|
|
Oncodaily, 21/10/2026
|
|
Dr CS Pramesh, Director of Tata Memorial Hospital and Professor and Head of Thoracic Surgery at Tata Memorial Centre in Mumbai, India, has been elected President-elect of the Union for International Cancer Control (UICC) for the 2026–2028 term...
|
|
|
|
|
| |
|
|
|
Cell Painting method reveals drug differences in 3D cancer cells.
|
|
News-Medical, 21/10/2026
|
|
Researchers grew bowel cancer cells as small spheres, or minispheres, in standard laboratory plates. They then made the minispheres transparent with a simple solution of sugar and glycerol, so the microscope could see individual cells deep inside them, and measured thousands...
|
|
|
|
|
|
|
|
|
2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|